T1	Chemical 0 12	Itraconazole 
T2	Gene_or_protein 44 50	CYP3A4 
T4	Chemical 101 110	midazolam 
T5	Chemical 113 122	triazolam 
T6	Chemical 125 134	buspirone 
T7	Chemical 137 147	lovastatin 
T8	Chemical 150 161	simvastatin 
T9	Chemical 166 175	oxycodone 
T10	Chemical 186 196	rifampicin 
T3	Pharmacodynamic_phenotype 101 110;78 89	midazolam exposure to
T11	Pharmacodynamic_phenotype 113 122;78 89	triazolam exposure to
T12	Pharmacodynamic_phenotype 125 134;78 89	buspirone exposure to
T13	Pharmacodynamic_phenotype 137 147;78 89	lovastatin exposure to
T14	Pharmacodynamic_phenotype 150 161;78 89	simvastatin exposure to
T15	Pharmacodynamic_phenotype 166 175;78 89	oxycodone exposure to
T16	Chemical 30 50	inhibitors of CYP3A4
T17	Pharmacodynamic_phenotype 219 240	plasma concentrations
R1	increases Arg1:T1 Arg2:T3	
R2	increases Arg1:T1 Arg2:T11	
R3	increases Arg1:T1 Arg2:T12	
R4	increases Arg1:T1 Arg2:T13	
R5	increases Arg1:T1 Arg2:T14	
R6	increases Arg1:T1 Arg2:T15	
R7	increases Arg1:T16 Arg2:T3	
R8	increases Arg1:T16 Arg2:T11	
R9	increases Arg1:T16 Arg2:T12	
R10	increases Arg1:T16 Arg2:T13	
R11	increases Arg1:T16 Arg2:T14	
R12	increases Arg1:T16 Arg2:T15	
R13	decreases Arg1:T10 Arg2:T3	
R14	decreases Arg1:T10 Arg2:T11	
R15	decreases Arg1:T10 Arg2:T12	
R17	decreases Arg1:T10 Arg2:T15	
R16	decreases Arg1:T10 Arg2:T13	
R18	decreases Arg1:T10 Arg2:T14	
R19	decreases Arg1:T10 Arg2:T17	
